Perrigo (PRGO) Dividends Paid - Common (2013 - 2026)
Perrigo's (PRGO) quarterly Dividends Paid - Common came in at $39.9 million in Q1 2026, down 1.72% year-on-year from $40.6 million in Q1 2025, and little changed on a QoQ basis from $39.9 million in Q4 2025.
Perrigo (PRGO) Dividends Paid - Common (2013 - 2026) Analysis & Trends
Perrigo (PRGO) has 14 years of Dividends Paid - Common data on file, last reported at $39.9 million in Q1 2026.
- On a quarterly basis, Dividends Paid - Common fell 1.72% year-over-year to $39.9 million in Q1 2026; TTM through Mar 2026 was $158.6 million, a 1.99% increase from a year earlier, with the FY2025 full-year figure at $159.3 million, up 4.46% from the prior year.
- Dividends Paid - Common for Q1 2026 stood at $39.9 million, roughly flat from $39.9 million in the prior quarter.
- Over the last five years, Dividends Paid - Common for PRGO reached as high as $40.6 million in Q1 2025 and fell as low as $34.2 million in Q2 2022.
- Historically, Dividends Paid - Common has averaged $37.9 million across 5 years, with a median of $37.6 million in 2023.
- Across the five-year window, Dividends Paid - Common advanced 14.37% in 2022 and declined 3.34% in 2024, its largest moves.
- Year by year, Dividends Paid - Common stood at $35.4 million in 2022, then climbed by 6.21% to $37.6 million in 2023, then increased by 5.32% to $39.6 million in 2024, then increased by 0.76% to $39.9 million in 2025, then changed by 0.0% to $39.9 million in 2026.
- Per Business Quant data, the three most recent Dividends Paid - Common figures were $39.9 million in Q1 2026, $39.9 million in Q4 2025, and $39.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends Paid - Common (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 224.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 3.92 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 139.60 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Perrigo | 1.40 Bn | 1.05 Bn | 325.50 Mn | 39.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | 39.90 Mn |
| Mar 28, 2026 | 39.90 Mn |
| Dec 31, 2025 | 39.90 Mn |
| Dec 31, 2025 | 39.90 Mn |
| Sep 27, 2025 | 39.90 Mn |
| Sep 27, 2025 | 39.90 Mn |
| Jun 28, 2025 | 38.90 Mn |
| Jun 28, 2025 | 38.90 Mn |
| Mar 29, 2025 | 40.60 Mn |
| Mar 29, 2025 | 40.60 Mn |
| Dec 31, 2024 | 39.60 Mn |
| Dec 31, 2024 | 39.60 Mn |
| Sep 28, 2024 | 37.60 Mn |
| Sep 28, 2024 | 37.60 Mn |
| Jun 29, 2024 | 37.70 Mn |
| Jun 29, 2024 | 37.70 Mn |
| Mar 30, 2024 | 37.60 Mn |
| Mar 30, 2024 | 37.60 Mn |
| Dec 31, 2023 | 37.60 Mn |
| Dec 31, 2023 | 37.60 Mn |